NEOGENOMICS INC

By person

46 insiders · 202 transactions

There is no salary here to measure against. NEOGENOMICS INC's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

GENERAL ELECTRIC CO entity

Former 10% Owner

—

$199.78M (2)

−$199.78M

0.0000%

$0.00

−100.0%

JONES STEVEN C

Director

—

$61.47M (48)

−$61.47M

7,026,451

5.47%

$112.92M

−24.9%

SHOVLIN ROBERT J.

President, Clinical Services

—

$23.73M (12) scheduled

−$23.73M

150,101

0.1168%

$2.41M

+276.3%

CARDOZA GEORGE

President & COO, Lab Ops

—

$22.41M (9)

−$22.41M

264,157

0.2056%

$4.25M

+17.0%

VAN OORT DOUGLAS M

Director

—

$18.80M (4) scheduled

−$18.80M

2,483,797

1.93%

$39.91M

+24.2%

HIPP RAYMOND R

Director

—

$7.08M (6)

−$7.08M

66,800

0.0520%

$1.07M

−74.8%

BALLIET JENNIFER

VP and Chief Culture Officer

—

$5.13M (15) scheduled

−$5.13M

48,615

0.0378%

$781.24K

+173.0%

Bonello William

Chief Financial Officer

—

$3.94M (7) scheduled

−$3.94M

191,548

0.1491%

$3.08M

—

Brown Douglas Matthew

Chief Strategy Officer

—

$3.70M (3)

−$3.70M

158,684

0.1235%

$2.55M

+48.3%

Johnson Kevin C

Director

$301.60K (1)

$3.65M (5)

−$3.35M

37,398

0.0291%

$600.99K

−59.2%

ROSS STEVEN A

CIO

—

$1.43M (4) scheduled

−$1.43M

4,500

0.0035%

$72.32K

0.0%

CROWTHER BRUCE K

Director

—

$1.24M (3) scheduled

−$1.24M

65,120

0.0507%

$1.05M

+552.5%

Weiss Lawrence Martin

Chief Medical Officer

—

$1.03M (1) scheduled

−$1.03M

130,847

0.1018%

$2.10M

—

ALBITAR MAHER

Chief Medical Officer

—

$886.98K (2)

−$886.98K

165,992

0.1292%

$2.67M

−39.4%

BRODIE STEVEN G.

VP - Pharma Operations

—

$529.06K (3)

−$529.06K

45,953

0.0358%

$738.46K

+16.6%

Mallon Mark

Chief Executive Officer

$520.71K (1)

—

+$520.71K

368,051

0.2865%

$5.91M

—

Olivo Alicia C

EVP, GC & Business Development

—

$500.65K (7) scheduled

−$500.65K

90,875

0.0707%

$1.46M

+101.0%

TETRAULT LYNN A.

Director

$56.97K (1)

$505.14K (6)

−$448.17K

93,115

0.0725%

$1.50M

+13,634%

Aunan Greg D

Chief Accounting Officer

—

$321.40K (1)

−$321.40K

5,153

0.0040%

$82.81K

−66.5%

McKenzie Kathryn B

Chief Sustainability/Risk Ofcr

—

$275.57K (2) scheduled

−$275.57K

49,361

0.0384%

$793.23K

—

Sherman Jeffrey Scott

Chief Financial Officer

$262.43K (2)

—

+$262.43K

220,009

0.1712%

$3.54M

—

Zook Anthony P.

Chief Executive Officer

$248.87K (2)

—

+$248.87K

152,011

0.1183%

$2.44M

—

Stone Warren

Pres & Chief Operating Officer

$48.89K (1)

$276.68K (1) scheduled

−$227.79K

181,078

0.1409%

$2.91M

—

HANNAH ALISON L.

Director

$183.80K (1)

—

+$183.80K

131,023

0.1020%

$2.11M

+1,033%

Pedulla Denise E

General Counsel

—

$95.00K (1) scheduled

−$95.00K

60,643

0.0472%

$974.53K

+47.6%

Perez David Brian

Director

$76.30K (1)

—

+$76.30K

66,967

0.0521%

$1.08M

—

Kelly Michael Aaron

Director

$38.00K (1)

—

+$38.00K

72,086

0.0561%

$1.16M

—

Gunn Neil

Director

$34.98K (1)

—

+$34.98K

51,177

0.0398%

$822.42K

—

KANOVSKY STEPHEN M

Director

$31.12K (1)

—

+$31.12K

75,421

0.0587%

$1.21M

—

Smith Christopher M

Chief Executive Officer

—

641,585

0.4994%

$10.31M

—

Robison William J

Director

—

183,348

0.1427%

$2.95M

+4.1%

Gilbert Halley E

Chief Legal Officer

—

147,396

0.1147%

$2.37M

+53,694%

Sikri Vishal

President Advanced Diagnostics

—

127,716

0.0994%

$2.05M

+19,048%

Harris Melody

Chf Ops Off, Pres, Informatics

—

109,755

0.0854%

$1.76M

+2,651%

Kulkarni Shashikant

Chief Scientific Officer

—

82,673

0.0643%

$1.33M

+33.9%

Sholehvar David

President, Clinical Services

—

43,216

0.0336%

$694.48K

—

Morris Clive

President of Inivata

—

41,280

0.0321%

$663.37K

—

Wallar Gina M

President, Pharma Services

—

33,443

0.0260%

$537.43K

+629.6%

Williams Felicia

Director

—

30,237

0.0235%

$485.91K

—

Dieter Cynthia J

Chief Accounting Officer

—

29,765

0.0232%

$478.32K

—

Floegel Elizabeth

Director

—

23,590

0.0184%

$379.09K

—

Green Marjorie C

Director

—

22,964

0.0179%

$369.03K

—

Stahler Rachel A

Director

—

21,335

0.0166%

$342.85K

—

Daly David

Director

—

17,179

0.0134%

$276.07K

—

Virag Sharon

Chief Financial Officer

—

10,944

0.0085%

$175.87K

—

Kenny John P.

Director

—

5,893

0.0046%

$94.70K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Olivo Alicia C

25 Nov 2025

EVP, GC & Business Development

Sold after exercise

20,916

$12.00

$250.99K

Bonello William

24 Nov 2021

President, Informatics

Sold after exercise

25,000

$37.13

$928.25K

CROWTHER BRUCE K

8 Jun 2021

Director

Sold after exercise

20,734

$41.46

$859.63K

SHOVLIN ROBERT J.

25 May 2021

President, Clinical Services

Sold after exercise

130,604

$39.31

$5.13M

Weiss Lawrence Martin

14 Dec 2020

Chief Medical Officer

Sold after exercise

20,200

$51.06

$1.03M

BALLIET JENNIFER

11 Dec 2020

VP and Chief Culture Officer

Sold after exercise

15,000

$49.99

$749.85K

Bonello William

2 Dec 2020

President, Informatics

Sold after exercise

8,000

$46.80

$374.40K

CARDOZA GEORGE

25 Nov 2020

President, Pharma Services

Sold after exercise

77,074

$45.48

$3.51M

CARDOZA GEORGE

24 Nov 2020

President, Pharma Services

Sold after exercise

52,926

$45.19

$2.39M

VAN OORT DOUGLAS M

16 Nov 2020

Chairman and CEO

Sold after exercise

100,000

$42.34

$4.23M

VAN OORT DOUGLAS M

13 Nov 2020

Chairman and CEO

Sold after exercise

118,752

$41.56

$4.94M

VAN OORT DOUGLAS M

12 Nov 2020

Chairman and CEO

Sold after exercise

121,248

$42.18

$5.11M

Pedulla Denise E

10 Nov 2020

General Counsel

Sold after exercise

2,262

$42.00

$95.00K

CROWTHER BRUCE K

24 Sep 2020

Director

Sold after exercise

8,333

$35.01

$291.74K

CARDOZA GEORGE

6 Aug 2020

President, Pharma Services

Sold after exercise

82,500

$39.35

$3.25M

BALLIET JENNIFER

3 Aug 2020

VP and Chief Culture Officer

Sold after exercise

13,000

$39.25

$510.25K

Bonello William

3 Aug 2020

President, Informatics

Sold after exercise

22,000

$38.61

$849.42K

SHOVLIN ROBERT J.

30 Jul 2020

President, Clinical Services

Sold after exercise

81,356

$38.17

$3.11M

SHOVLIN ROBERT J.

4 Mar 2020

President, Clinical Services

Sold after exercise

98,093

$30.86

$3.03M

McKenzie Kathryn B

10 Dec 2019

Chief Accounting Officer

Sold after exercise

8,000

$26.37

$210.96K

BALLIET JENNIFER

15 Nov 2019

VP and Chief Culture Officer

Sold after exercise

6,833

$23.45

$160.23K

CARDOZA GEORGE

12 Nov 2019

President, Pharma Services

Sold after exercise

19,444

$23.15

$450.13K

CARDOZA GEORGE

6 Nov 2019

President, Pharma Services

Sold after exercise

51,556

$22.82

$1.18M

SHOVLIN ROBERT J.

31 Oct 2019

President, Clinical Services

Sold after exercise

70,473

$23.11

$1.63M

Bonello William

28 Aug 2019

Chief Strategy Officer

Sold after exercise

17,000

$24.83

$422.11K

HIPP RAYMOND R

23 Aug 2019

Director

Sold after exercise

600

$25.02

$15.01K

Bonello William

6 May 2019

Chief Strategy Officer

Sold after exercise

7,200

$23.53

$169.42K

SHOVLIN ROBERT J.

2 May 2019

President, Clinical Services

Sold after exercise

66,667

$22.14

$1.48M

SHOVLIN ROBERT J.

2 May 2019

President, Clinical Services

Sold after exercise

52,680

$22.14

$1.17M

BALLIET JENNIFER

4 Mar 2019

VP and Chief Culture Officer

Sold after exercise

14,000

$19.09

$267.26K

BALLIET JENNIFER

28 Feb 2019

VP and Chief Culture Officer

Sold after exercise

30,000

$19.57

$587.10K

HIPP RAYMOND R

26 Feb 2019

Director

Sold after exercise

18,889

$18.90

$357.00K

Bonello William

26 Feb 2019

Chief Strategy Officer

Sold after exercise

60,203

$18.90

$1.14M

SHOVLIN ROBERT J.

26 Feb 2019

President, Clinical Services

Sold after exercise

141,879

$18.88

$2.68M

SHOVLIN ROBERT J.

9 Nov 2018

President, Clinical Services

Sold after exercise

180,000

$17.05

$3.07M

BALLIET JENNIFER

9 Nov 2018

VP and Chief Culture Officer

Sold after exercise

39,828

$17.00

$677.08K

BALLIET JENNIFER

29 May 2018

VP and Chief Culture Officer

Sold after exercise

35,000

$11.70

$409.50K

BALLIET JENNIFER

29 May 2018

VP and Chief Culture Officer

Sold after exercise

30,000

$11.62

$348.60K

BALLIET JENNIFER

15 May 2018

VP and Chief Culture Officer

Sold after exercise

6,500

$11.26

$73.19K

BALLIET JENNIFER

15 May 2018

VP and Chief Culture Officer

Sold after exercise

6,500

$11.21

$72.87K

ROSS STEVEN A

10 May 2018

CIO

Sold after exercise

81,999

$10.78

$883.95K

ROSS STEVEN A

2 Jun 2017

CIO

Sold after exercise

10,000

$7.79

$77.90K

ROSS STEVEN A

2 Jun 2017

CIO

Sold after exercise

15,000

$7.63

$114.45K

Show all 202 transactions →

By person

Individual transactions

What was left out